N-[(2H-1,3-Benzodioxol-5-yl)methyl]-3-cyclopentyl-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxamide

Catalog No. :
ACFWJR026
CAS No. :
909207-97-2
Molecular Formula :
C22H21N3O5
Molecular Weight :
407.43

IUPAC Name:N-(benzo[d][1,3]dioxol-5-ylmethyl)-3-cyclopentyl-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxamide

N-[(2H-1,3-Benzodioxol-5-yl)methyl]-3-cyclopentyl-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$225.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-[(2H-1,3-Benzodioxol-5-yl)methyl]-3-cyclopentyl-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxamide
IUPAC NameN-(benzo[d][1,3]dioxol-5-ylmethyl)-3-cyclopentyl-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxamide
MDL No.MFCD15082356
Molecular FormulaC22H21N3O5
Molecular Weight407.43
SMILESO=C(C1=CC(NC(N2C3CCCC3)=O)=C(C=C1)C2=O)NCC4=CC=C(OCO5)C5=C4
InChI KeyFQQUMNHCVSJLIV-UHFFFAOYSA-N
SynonymN-[(2H-1,3-benzodioxol-5-yl)methyl]-3-cyclopentyl-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxamide;7-Quinazolinecarboxamide, N-(1,3-benzodioxol-5-ylmethyl)-3-cyclopentyl-1,2,3,4-tetrahydro-2,4-dioxo-
CAS No.909207-97-2

Synthetic Route by SureRoute

1. ACFWJR026 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOYZH267 route compound structure diagram
    ACOYZH2672620-50-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFWJR026 route product structure diagram
    ACFWJR026909207-97-2
Inquiry

2. ACFWJR026 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOYZH267 route compound structure diagram
    ACOYZH2672620-50-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFWJR026 route product structure diagram
    ACFWJR026909207-97-2
Inquiry

Comments (0)